Thermo Fisher doubles profits on back of covid treatments

The firm recorded a revenue boost 'due to the sales of products addressing the diagnosis and treatment of covid'.

The main Irish arm of pharma firm, Thermo Fisher Scientific, last year received a once-off pay-out of €10m to settle a dispute relating to the interpretation of certain payments.

New accounts show that before the payment was received, Thermo Fisher Scientific Cork Ltd’s pre-tax profits more than doubled to €17.6m in 2021.